image
Healthcare - Biotechnology - NASDAQ - US
$ 3.69
0.545 %
$ 5.69 M
Market Cap
-1.21
P/E
BALANCE SHEET
10.6 M ASSETS
-27.96%
810 K LIABILITIES
-24.56%
9.8 M EQUITY
-28.22%
BALANCE SHEET DECOMPOSITION
Balance Sheet Decomposition Xenetic Biosciences, Inc.
image
Current Assets 9.59 M
Cash & Short-Term Investments 8.98 M
Receivables 0
Other Current Assets 604 K
Non-Current Assets 1.02 M
Long-Term Investments 0
PP&E 0
Other Non-Current Assets 1.02 M
Current Liabilities 810 K
Accounts Payable 241 K
Short-Term Debt 0
Other Current Liabilities 569 K
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0

Balance Sheet

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017 Dec-2016 Dec-2015 Dec-2014 Dec-2013 Dec-2012 Aug-2011
ASSETS
Cash & Cash Equivalents 9.0 13.1 18.2 11.5 10.4 0.6 5.5 4.0 0.1 2.5 4.8 11.1 10 K
Short Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Receivables 0 0 0 0 0 0 0 3.0 0 0.1 0.3 0.2 0
Inventory 0 0 0 0 0 0 0 1 0 0 0 0 0
Other Current Assets 0.6 0.6 0.3 0.2 0.2 0.6 0.4 1.3 4.1 88.2 K 0.2 0.2 0
Total Current Assets 9.6 13.7 18.7 12.4 11.1 1.2 5.9 8.3 4.2 2.8 5.3 11.5 10 K
PP&E 0 0 0 27 K 757 4.96 K 27.8 K 42.4 K 62 K 0.1 0.2 0.1 0.2
Intangible Assets 0 0 0 0 9.2 9.2 9.2 9.2 9.2 9.8 10.3 10.1 0
Goodwill 0 0 0 0 9.2 3.3 3.3 3.3 3.3 3.5 3.7 3.6 0
Long Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Long Term Assets 1.0 1.1 1.1 0.8 1.2 0.7 0.7 66.3 K 0.1 0.2 0 (13.8) 0
Other Assets 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Assets 10.6 14.7 19.8 13.2 21.5 14.4 19.2 21.0 16.9 16.3 19.5 25.4 0.2
LIABILITIES
Accounts Payable 0.2 0.3 0.4 0.3 0.9 0.9 0.8 1.0 1.8 0.9 0.9 0.1 7.37 K
Short Term Debt 0 0 27 K 0 0 0 0 0 4.0 0.4 0.7 0.7 0
Other Current Liabilities 0.6 0.8 1.0 0.6 0.5 0.7 1.2 0.9 1.5 1.5 1.9 0.5 548
Total Current Liabilities 0.8 1.1 1.4 0.9 1.4 1.6 1.9 1.9 7.3 2.7 3.6 1.4 7.92 K
Long Term Debt 0 0 0 27 K 0 0 0 0 0 0 0 0.2 0.2
Deferred Tax Income 0 0 0 27 K 2.9 2.9 2.9 2.9 2.9 3.1 3.3 3.2 0
Other Liabilities 0 0 0 27 K 0 0 0 19.9 K 38.8 K 56.4 K 0 (0.2) 0
Total Liabilities 0.8 1.1 1.4 1.0 4.3 4.5 4.9 4.8 10.3 5.8 6.8 4.6 0.2
EQUITY
Common Stock 1.54 K 15.2 K 13.5 K 8.77 K 6.09 K 9.73 K 9.04 K 8.73 K 0.2 1.5 1.3 1.3 10 K
Retained Earnings (193.2) (189.1) (182.5) (176.9) (166.0) (153.2) (145.9) (142.3) (88.1) (75.6) (58.3) (49.7) 8.24 K
Other Accumulative Comprehensive Income/Loss 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.6 0.9 0.9 0
Total Equity 9.8 13.6 18.4 12.2 17.2 9.9 14.3 16.2 6.6 10.5 12.6 20.8 1.76 K
Total Liabilities and Equity 10.6 14.7 19.8 13.2 21.5 14.4 19.2 21.0 16.9 16.3 19.5 25.4 0.2
SHARES OUTSTANDING
Common Shares Outstanding 1.5 1.4 1.0 0.6 0.3 75.6 K 72.2 K 61.9 K 35.2 K 34.3 K 3.03 K 3.02 K